1. Miller DL, Hutchins J, Ferguson MA, Barhoush Y, Achter E, Kuckelman JP. Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention. Pain Ther. 2025 Feb;14(1):317-328.

2. Shoaib S, Feliciano J, Dasenbrook EC, Maynard J, Batchu L, Mohanty M, Lauterio M, Feld AJ. Real-world disease burden, mortality, and healthcare resource utilization associated with bronchiectasis. Chron Respir Dis. 2025 Jan-Dec;22:14799731241310897.

3. Vo R, Barhoush Y, Batchu L, Adams S, Setzen G. All-cause claims analysis of the LATERA absorbable nasal implant vs surgical repair in patients with nasal valve collapse. J Med Econ. 2024 Jan-Dec;27(1):1099-1107.

4. Seigel L, Shoaib S, Maughn K, Foster M, Shah S, Batchu L, Wittstock K, Alexis A. Health disparities in psoriasis: geographic barriers to access in the United States. J Dermatolog Treat. 2024 Dec;35(1):2365820.

5. Zhao R, Ding Z, Gupta P, Gozalo L, Bruette R, Johnson VM, Maughn K, Liu Y, Kachroo S. Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn's Disease Initiating Biologics With 3 Years of Follow-Up. J Health Econ Outcomes Res. 2023 Nov 20;10(2):111-120.

6. Navari RM, Nelson WW, Shoaib S, Singh R, Zhang W, Bailey WL. Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy. Adv Ther. 2023 Jul;40(7):3217-3226.

7. Escobar M, Bullano M, Mokdad AG, Caicedo J, Schultz BG, Fan Q, Verma S. A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors. Expert Rev Hematol. 2023 Jun;16(6):467-474.

8. Terrault N, Dieyi C, Trivedi R, Coppola R, Maynard J, Reau N, Satram S, Chattergoon M. Prevalence of hepatitis B and D virus among a nationally representative insured population in the United States. AASLD The Liver Meeting. Boston, MA: Nov 10-14, 2023.

9. Karlitz J, Liu Y, Gupta P, Aweh G, Chung K. Burden of liver cancer among Medicaid-insured patients: A retrospective analysis of a national all-payer claims database. American College of Gastroenterology (ACG) Annual Scientific Meeting. Vancouver, CA: Oct 20-25, 2023.

10. Holman D, Drayton D, Pandit M, Diaz A, Maughn K, Dieyi C, Achter E, Peeples H. Effects of insurance coverage and antiseizure medication formulary policies on the experiences of patients with epilepsy and healthcare professionals: A qualitative study. Academy of Managed Care Pharmacy (AMCP) Nexus 2023. Orlando, FL: Oct 16-19, 2023.

1. Meijerink H, Shelil M, Jani-Bølstad J, Dvergsdal ET, Madslien EH, Wilberg M, Gundersen RB, Sæbø JI, Thorseng AA, Iversen BG. Does integration with national registers improve the data completeness of local COVID-19 contact tracing tools? A register-based study in Norway, May 2020 - September 2021. BMC Health Serv Res. 2024 Jan 17;24(1):96.

2. Hansen BT, Klungsøyr O, Labberton AS, Sääksvuori L, Rydland KM, Ødeskaug LE, Wisløff T, Meijerink H. Effectiveness of Text Messaging Nudging to Increase Coverage of Influenza Vaccination Among Older Adults in Norway (InfluSMS Study): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Feb 25;14:e63938.

3. Buer S, Hagen BI, Søraas A, White RA, Bø R, Ellingjord-Dale M, Istre MS, Brunvoll SH, Lerdal A, Landrø NI, Nygaard AB, Stubberud J. Executive deficits after SARS-CoV-2 infection: A cross-sectional population study. Brain Behav Immun Health. 2024 Sep 10;41:100857.

4. Rykkelid M, Wennberg HM, Richardsen E, Sørbye SW. Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022. Pathogens. 2024 May 2;13(5):381.

5. Dong L, Nygård M, Støer NC, Klungsøyr O, Hansen BT. Real‐world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination. International Journal of Cancer. 2023 Jul 15;153(2):399-406.

6. Nilsen TS, Gulseth HL, Daae A, Indseth T. Coronavirus immunisation abroad among foreign-born persons in Norway. Tidsskr Nor Laegeforen. 2022 Jun 27;142(10). English, Norwegian.

7. Hagerup-Jenssen M, Kongsrud S, Riise ØR. Suboptimal MMR2 vaccine coverage in six counties in Norway detected through the national immunisation registry, April 2014 to April 2017. Euro Surveill. 2017 Apr 27;22(17):30518.

8. Riise ØR, Laake I, Bergsaker MA, Nøkleby H, Haugen IL, Storsæter J. Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years. BMC Pediatr. 2015 Nov 13;15:180.

9. Riise O. 1066: Delay in the Norwegian Immunisation Programme. Open Forum Infect Dis. 2014 Dec;1(Suppl 1):S312–3.

10. Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013 Dec 16;31(52):6232-8.

1. Uslu S, Gülle S, Sen G, Capar S, Senel S, Dalkılıc E, Akar S, Koca SS, Tufan A, Yazici A, Yilmaz S, Inanc N, Birlik M, Solmaz D, Cefle A, Goker B, Direskeneli H, Yolbas S, Steen Krogh N, Yilmaz N, Erten S, Bes C, Soysal Gündüz O, Oztürk MA, Haznedaroglu S, Yavuz S, Onen F, Sari I. Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis. J Clin Med. 2024 Nov 29;13(23):7266.

2. Ørnbjerg LM, Brahe CH, Linde L, Jacobsson L, Nissen MJ, Kristianslund EK, Santos MJ, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Barcelos A, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, Mann H, Pavelka K, van de Sande M, van der Horst-Bruinsma IE, Suarez MP, Sánchez-Piedra C, Macfarlane GJ, Iannone F, Michelsen B, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML. Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment. Joint Bone Spine. 2024 Jul;91(4):105729.

3. Uslu S, Gulle S, Sen G, Cefle A, Yilmaz S, Kocaer SB, Yuce Inel T, Koca SS, Yolbas S, Ozturk MA, Senel S, Inanc N, Dalkilic HE, Soysal Gunduz O, Tufan A, Akar S, Birlik AM, Sari I, Akkoc N, Onen F. Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study. Sci Rep. 2024 Jun 20;14(1):14194.

4. Karakaş A, Gulle S, Can G, Dalkılıc E, Akar S, Koca SS, Pehlivan Y, Senel S, Tufan A, Ozturk MA, Yilmaz S, Yazici A, Cefle A, Yüce İnel T, Erez Y, Sari I, Birlik M, Direskeneli H, Akkoc N, Onen F. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry. Mod Rheumatol. 2024 Mar 28;34(3):584-591.

5. Uslu S, Gülle S, Urak Ö, Şen G, Dalkılıç E, Şenel S, Akar S, İnanç N, Cefle A, Köken Avşar A, Yolbaş S, Yılmaz S, Soysal Gündüz Ö, Sarı İ, Birlik M, Akkoç N, Önen F. Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results. Arch Rheumatol. 2024 Mar 20;39(2):232-241.

6. Inanc N, Abacar KY, Ozturk MA, Tufan A, Karadeniz H, Sari I, Can G, Erez Y, Pehlivan Y, Dalkilic HE, Ocak T, Cefle A, Yazici A, Senel AS, Akar S, Durak-Ediboğlu E, Koca SS, Piskin-Sagir R, Yilmaz S, Gulcemal S, Soysal-Gunduz O, Basibuyuk CS, Alkan S, Cesur TY, Onen F. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. J Clin Rheumatol. 2023 Dec 1;29(8):365-369.

7. Tuğsal HY, Artin GK, Can G, Çapar S, Zengin B, Akar S, Dalkiliç HE, Şenel AS, Koca SS, Göker B, Yazici A, İnanç GN, Ellidokuz H, Akkoç N, Önen F. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis. Turk J Med Sci. 2023 Aug;53(4):970-978.

8. Karataş A, Pişkin Sağir R, Koca SS, Dalkiliç E, Can G, Pehlivan Y, Yazici A, Inanç N, Cefle A, Ertürk Z, Akar S, Şenel S, Birlik M, Akkoç N, Önen F. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry. Turk J Med Sci. 2023 Jun 21;53(5):1321-1329.

9. Yazici A, Özdemir Işık Ö, Dalkılıç E, Koca SS, Pehlivan Y, Şenel S, Inanc N, Akar S, Yılmaz S, Soysal Gündüz Ö, Cefle A, Karakaş ÖF, Onen F. A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry. Sci Rep. 2022 Dec 20;12(1):21972.

10. Önen F, Can G, Çapar S, Dalkılıç E, Pehlivan Y, Şenel S, Akar S, Koca SS, Tufan A, Yazıcı A, Yılmaz S, İnanç N, Sarı İ, Birlik M, Solmaz D, Cefle A, Öztürk MA, Yolbaş S, Krogh NS, Yılmaz N, Erten Ş, Bes C, Gündüz ÖS, Göker B, Haznedaroğlu S, Yavuz Ş, Yildirim Çetin G, Yıldız F, Direskeneli H, Akkoç N. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry. Eur J Rheumatol. 2022 Apr;9(2):82-87.